Reproducibility of fMRI in the clinical setting: Implications for trial designs

R. Bosnell, C. Wegner, Z. T. Kincses, T. Korteweg, F. Agosta, O. Ciccarelli, N. De Stefano, A. Gass, J. Hirsch, H. Johansen-Berg, L. Kappos, F. Barkhof, L. Mancini, F. Manfredonia, S. Marino, D. H. Miller, X. Montalban, J. Palace, M. Rocca, C. EnzingerS. Ropele, A. Rovira, S. Smith, A. Thompson, J. Thornton, T. Yousry, B. Whitcher, M. Filippi, P. M. Matthews

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

With expanding potential clinical applications of functional magnetic resonance imaging (fMRI) it is important to test how reliable different measures of fMRI activation are between subjects and sessions and between centres. This study compared variability across 17 patients with multiple sclerosis (MS) and 22 age-matched healthy controls (HC) in 5 European centres performing an fMRI block design with hand tapping. We recruited subjects from sites using 1.5 T scanners from different manufacturers. 5 healthy volunteers also were studied at each of 4 of the centres. We found that reproducibility between runs and sessions for single individuals was consistently much greater than between individuals. There was greater run-to-run variability for MS patients than for HC. Measurements of maximum signal change (MSC) appeared to provide higher reproducibility within individuals and greater sensitivity to differences between individuals than region of interest (ROI) suprathreshold voxel counts. The variability in measurements between centres was not as great as that between individuals. Consistent with these observations, we estimated that power should not be reduced substantially with use of multi-, as opposed to single-, centre study designs with similar numbers of subjects. Multi-centre interventional studies in which fMRI is used as an outcome measure thus appear practical even when implemented in conventional clinical environments.

Original languageEnglish
Pages (from-to)603-610
Number of pages8
JournalNeuroImage
Volume42
Issue number2
DOIs
Publication statusPublished - Aug 15 2008

Fingerprint

Magnetic Resonance Imaging
Multiple Sclerosis
Individuality
Healthy Volunteers
Hand
Outcome Assessment (Health Care)

Keywords

  • Clinical trial
  • Functional magnetic resonance imaging
  • Multiple sclerosis
  • Plasticity

ASJC Scopus subject areas

  • Cognitive Neuroscience
  • Neurology

Cite this

Bosnell, R., Wegner, C., Kincses, Z. T., Korteweg, T., Agosta, F., Ciccarelli, O., ... Matthews, P. M. (2008). Reproducibility of fMRI in the clinical setting: Implications for trial designs. NeuroImage, 42(2), 603-610. https://doi.org/10.1016/j.neuroimage.2008.05.005

Reproducibility of fMRI in the clinical setting : Implications for trial designs. / Bosnell, R.; Wegner, C.; Kincses, Z. T.; Korteweg, T.; Agosta, F.; Ciccarelli, O.; De Stefano, N.; Gass, A.; Hirsch, J.; Johansen-Berg, H.; Kappos, L.; Barkhof, F.; Mancini, L.; Manfredonia, F.; Marino, S.; Miller, D. H.; Montalban, X.; Palace, J.; Rocca, M.; Enzinger, C.; Ropele, S.; Rovira, A.; Smith, S.; Thompson, A.; Thornton, J.; Yousry, T.; Whitcher, B.; Filippi, M.; Matthews, P. M.

In: NeuroImage, Vol. 42, No. 2, 15.08.2008, p. 603-610.

Research output: Contribution to journalArticle

Bosnell, R, Wegner, C, Kincses, ZT, Korteweg, T, Agosta, F, Ciccarelli, O, De Stefano, N, Gass, A, Hirsch, J, Johansen-Berg, H, Kappos, L, Barkhof, F, Mancini, L, Manfredonia, F, Marino, S, Miller, DH, Montalban, X, Palace, J, Rocca, M, Enzinger, C, Ropele, S, Rovira, A, Smith, S, Thompson, A, Thornton, J, Yousry, T, Whitcher, B, Filippi, M & Matthews, PM 2008, 'Reproducibility of fMRI in the clinical setting: Implications for trial designs', NeuroImage, vol. 42, no. 2, pp. 603-610. https://doi.org/10.1016/j.neuroimage.2008.05.005
Bosnell, R. ; Wegner, C. ; Kincses, Z. T. ; Korteweg, T. ; Agosta, F. ; Ciccarelli, O. ; De Stefano, N. ; Gass, A. ; Hirsch, J. ; Johansen-Berg, H. ; Kappos, L. ; Barkhof, F. ; Mancini, L. ; Manfredonia, F. ; Marino, S. ; Miller, D. H. ; Montalban, X. ; Palace, J. ; Rocca, M. ; Enzinger, C. ; Ropele, S. ; Rovira, A. ; Smith, S. ; Thompson, A. ; Thornton, J. ; Yousry, T. ; Whitcher, B. ; Filippi, M. ; Matthews, P. M. / Reproducibility of fMRI in the clinical setting : Implications for trial designs. In: NeuroImage. 2008 ; Vol. 42, No. 2. pp. 603-610.
@article{f37670f5dd274d5a8909cf4f8db8dfb2,
title = "Reproducibility of fMRI in the clinical setting: Implications for trial designs",
abstract = "With expanding potential clinical applications of functional magnetic resonance imaging (fMRI) it is important to test how reliable different measures of fMRI activation are between subjects and sessions and between centres. This study compared variability across 17 patients with multiple sclerosis (MS) and 22 age-matched healthy controls (HC) in 5 European centres performing an fMRI block design with hand tapping. We recruited subjects from sites using 1.5 T scanners from different manufacturers. 5 healthy volunteers also were studied at each of 4 of the centres. We found that reproducibility between runs and sessions for single individuals was consistently much greater than between individuals. There was greater run-to-run variability for MS patients than for HC. Measurements of maximum signal change (MSC) appeared to provide higher reproducibility within individuals and greater sensitivity to differences between individuals than region of interest (ROI) suprathreshold voxel counts. The variability in measurements between centres was not as great as that between individuals. Consistent with these observations, we estimated that power should not be reduced substantially with use of multi-, as opposed to single-, centre study designs with similar numbers of subjects. Multi-centre interventional studies in which fMRI is used as an outcome measure thus appear practical even when implemented in conventional clinical environments.",
keywords = "Clinical trial, Functional magnetic resonance imaging, Multiple sclerosis, Plasticity",
author = "R. Bosnell and C. Wegner and Kincses, {Z. T.} and T. Korteweg and F. Agosta and O. Ciccarelli and {De Stefano}, N. and A. Gass and J. Hirsch and H. Johansen-Berg and L. Kappos and F. Barkhof and L. Mancini and F. Manfredonia and S. Marino and Miller, {D. H.} and X. Montalban and J. Palace and M. Rocca and C. Enzinger and S. Ropele and A. Rovira and S. Smith and A. Thompson and J. Thornton and T. Yousry and B. Whitcher and M. Filippi and Matthews, {P. M.}",
year = "2008",
month = "8",
day = "15",
doi = "10.1016/j.neuroimage.2008.05.005",
language = "English",
volume = "42",
pages = "603--610",
journal = "NeuroImage",
issn = "1053-8119",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Reproducibility of fMRI in the clinical setting

T2 - Implications for trial designs

AU - Bosnell, R.

AU - Wegner, C.

AU - Kincses, Z. T.

AU - Korteweg, T.

AU - Agosta, F.

AU - Ciccarelli, O.

AU - De Stefano, N.

AU - Gass, A.

AU - Hirsch, J.

AU - Johansen-Berg, H.

AU - Kappos, L.

AU - Barkhof, F.

AU - Mancini, L.

AU - Manfredonia, F.

AU - Marino, S.

AU - Miller, D. H.

AU - Montalban, X.

AU - Palace, J.

AU - Rocca, M.

AU - Enzinger, C.

AU - Ropele, S.

AU - Rovira, A.

AU - Smith, S.

AU - Thompson, A.

AU - Thornton, J.

AU - Yousry, T.

AU - Whitcher, B.

AU - Filippi, M.

AU - Matthews, P. M.

PY - 2008/8/15

Y1 - 2008/8/15

N2 - With expanding potential clinical applications of functional magnetic resonance imaging (fMRI) it is important to test how reliable different measures of fMRI activation are between subjects and sessions and between centres. This study compared variability across 17 patients with multiple sclerosis (MS) and 22 age-matched healthy controls (HC) in 5 European centres performing an fMRI block design with hand tapping. We recruited subjects from sites using 1.5 T scanners from different manufacturers. 5 healthy volunteers also were studied at each of 4 of the centres. We found that reproducibility between runs and sessions for single individuals was consistently much greater than between individuals. There was greater run-to-run variability for MS patients than for HC. Measurements of maximum signal change (MSC) appeared to provide higher reproducibility within individuals and greater sensitivity to differences between individuals than region of interest (ROI) suprathreshold voxel counts. The variability in measurements between centres was not as great as that between individuals. Consistent with these observations, we estimated that power should not be reduced substantially with use of multi-, as opposed to single-, centre study designs with similar numbers of subjects. Multi-centre interventional studies in which fMRI is used as an outcome measure thus appear practical even when implemented in conventional clinical environments.

AB - With expanding potential clinical applications of functional magnetic resonance imaging (fMRI) it is important to test how reliable different measures of fMRI activation are between subjects and sessions and between centres. This study compared variability across 17 patients with multiple sclerosis (MS) and 22 age-matched healthy controls (HC) in 5 European centres performing an fMRI block design with hand tapping. We recruited subjects from sites using 1.5 T scanners from different manufacturers. 5 healthy volunteers also were studied at each of 4 of the centres. We found that reproducibility between runs and sessions for single individuals was consistently much greater than between individuals. There was greater run-to-run variability for MS patients than for HC. Measurements of maximum signal change (MSC) appeared to provide higher reproducibility within individuals and greater sensitivity to differences between individuals than region of interest (ROI) suprathreshold voxel counts. The variability in measurements between centres was not as great as that between individuals. Consistent with these observations, we estimated that power should not be reduced substantially with use of multi-, as opposed to single-, centre study designs with similar numbers of subjects. Multi-centre interventional studies in which fMRI is used as an outcome measure thus appear practical even when implemented in conventional clinical environments.

KW - Clinical trial

KW - Functional magnetic resonance imaging

KW - Multiple sclerosis

KW - Plasticity

UR - http://www.scopus.com/inward/record.url?scp=48149091421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48149091421&partnerID=8YFLogxK

U2 - 10.1016/j.neuroimage.2008.05.005

DO - 10.1016/j.neuroimage.2008.05.005

M3 - Article

C2 - 18579411

AN - SCOPUS:48149091421

VL - 42

SP - 603

EP - 610

JO - NeuroImage

JF - NeuroImage

SN - 1053-8119

IS - 2

ER -